Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.

Medios AG

Medios is involved in the specialty pharmaceuticals sector, ensuring that innovative medication therapies reach patients across Europe.

XETRA:ILM1

Medios

Last Close

16.22

25/09 13:59

Market Cap

411.66M

Beta: 1.25

Volume Today

20.11K

Avg: 22.94K

PE Ratio

19.67

PFCF: 13.46